“Receiving non-GMO and kosher verification is one more important milestone for us as we work hard to provide our customers with the ingredients they need to better serve their consumers,” said ENI CEO Cal Bewicke. “We’re very pleased that a trusted third-party organization like Eurofins has validated our commitment to provide only the best quality, tested vegetable-source glucosamine.”
GreenGrown is a vegan, microbial-fermentation-derived glucosamine. ENI recently licensed patents from Arkion Life Sciences for the production process using microbial fermentation.
The vegetable source is guaranteed via ENI’s patented ISCT (Isotopic Signature Carbon Tracing) method, said the company.GreenGrown is also shellfish free, and is manufactured under cGMPs (current Good Manufacturing Practices).
Joint health segment
The joint health segment is dominated by combination products containing glucosamine and chondroitin sulfate, driven by positive data from big studies like GAIT and demand from aging consumers to naturally support their joints. (Pharmaceutical solutions include non-steroidal anti-inflammatory drugs (NSAIDs), but these have been linked with gastrointestinal toxicity, increased blood pressure, and increased risk of cardiovascular disease.)
Glucosamine and chondroitin have faced pressures in the market, however, with the emergence of multiple scientifically-supported joint health ingredients and increased consumer interest in sourcing driving a downturn for the ingredients.
And the demand is particularly strong for vegetarian sourced glucosamine, where Regenasure by Cargill (manufactured through conversion of fungal biomass) and GlucosaGreen by TSI USA play alongside ENI’s GreenGrown Glucosamine.